Taxotere Permanent Hair Loss Warnings Were Issued in the E.U. Ten Years Earlier That in the U.S. – Why?

by KJ McElrath | Jul 3, 2018 | Taxotere |

Taxotere (docetaxel anhydrous) is a chemotherapy drug commonly used to treat metastatic breast...

Taxotere Claims Jump 8% in One Month

by KJ McElrath | Apr 21, 2017 | Taxotere |

There has been a recent spike in the number of lawsuits against Taxotere maker Sanofi-Aventis over...

More Than Hair Loss: The Connection Between Taxotere and Typhlitis

by KJ McElrath | Mar 3, 2017 | Taxotere |

Recently, French oncologists received a letter from that country’s National Drug and Health...

Did Taxotere Manufacturer Sanofi Deliberately Hide The Drug’s Side Effects?

by KJ McElrath | Nov 5, 2016 | Taxotere |

Drugs used in chemotherapy for cancer patients have numerous side effects, one of which is hair...

Drugmaker Sanofi-Aventis Made Big Claims About Taxotere That Weren’t True

by KJ McElrath | Aug 24, 2016 | Taxotere |

A patient who undergoes chemotherapy for the treatment of cancer can expect hair loss, among other...

Taxotere Chemo Drug Causing Unnecessary Permanent Hair Loss

by Mike Papantonio | Feb 25, 2016 | Taxotere |

Taxotere is an unnecessary chemo drug that is adding even more suffering to women’s lives by...